Document Detail

Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling.
MedLine Citation:
PMID:  19951746     Owner:  NLM     Status:  MEDLINE    
Thyroid hormone (TH), apart from its "classical" actions on cardiac contractility and heart rhythm, appears to regulate various intracellular signalling pathways related to response to stress and cardiac remodelling. There is now accumulating experimental and clinical evidence showing a beneficial effect of TH on limiting myocardial ischaemic injury, preventing/reversing post infarction cardiac remodelling and improving cardiac hemodynamics. Thyroid analogs have already been developed and may allow TH use in clinical practice. However, the efficacy of TH in the treatment of cardiac diseases is now awaiting to be tested in large clinical trials.
Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Related Documents :
6448416 - The effect of pregnancy and lactation on the development of experimental heart lesions.
2949586 - Selective effects of pn 200-110 (isradipine) on the peripheral circulation and the heart.
11156666 - Prediction of contractile reserve by cyclic variation of integrated backscatter of the ...
9500876 - Myocardial function in the working mouse heart overexpressing cardiac a1 adenosine rece...
6119876 - Beta blockade and the secondary prevention of myocardial infarction.
17963506 - Association of sicam-1 and mcp-1 with coronary artery calcification in families enriche...
Publication Detail:
Type:  Journal Article; Review     Date:  2009-11-29
Journal Detail:
Title:  Vascular pharmacology     Volume:  52     ISSN:  1879-3649     ISO Abbreviation:  Vascul. Pharmacol.     Publication Date:    2010 Mar-Apr
Date Detail:
Created Date:  2010-02-26     Completed Date:  2010-05-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130615     Medline TA:  Vascul Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  157-65     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Elsevier Inc. All rights reserved.
Department of Pharmacology, University of Athens, School of Medicine, 75 Mikras Asias Ave., 11527 Goudi, Athens, Greece.,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hemodynamics / drug effects
Myocardial Contraction / physiology
Myocardial Ischemia / drug therapy*,  physiopathology
Signal Transduction / drug effects
Thyroid Hormones / metabolism,  therapeutic use*
Ventricular Remodeling / drug effects*
Reg. No./Substance:
0/Thyroid Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: Current perspectiv...
Next Document:  Investigation of the immunosuppressive activity of Physalin H on T lymphocytes.